Board Member Dances for The Longest Day
It turns out the best activity to lower your risk of Alzheimer’s disease is dance. When she heard this, Nancy Westcott got an idea. Nancy is a board member for the Northern California and...
It turns out the best activity to lower your risk of Alzheimer’s disease is dance. When she heard this, Nancy Westcott got an idea. Nancy is a board member for the Northern California and...
“What if there is something to the fountain of youth?” asks Tony Wyss-Coray, Professor of Neurology at Stanford University. Dr. Wyss-Coray relies on science over ancient tales, but he does believe there are factors...
The Alzheimer’s Association spoke with TrialMatch user Wanda Young about her participation in clinical studies. Wanda is caregiver for her husband, mother and brother, all of whom have forms of dementia. She is participating...
A Bay Area researcher was recently featured on the cover of Time Magazine for his team’s pioneering work on Alzheimer’s therapeutics. Frank M. Longo, MD, PhD, is Professor and Chairman of the Department of Neurology and...
Dr. Kaci Fairchild is a licensed clinical psychologist whose research focuses on the non-pharmacological rehabilitation of late life cognitive impairment and neuropsychiatric disorders. She recently received the Alzheimer’s Association new investigator grant award which...
What is preclinical Alzheimer’s disease? Preclinical Alzheimer’s is a newly defined stage of the disease reflecting current evidence that changes in the brain may occur years before symptoms affecting memory, thinking or behavior can...
What if we could diagnose Alzheimer’s before symptoms started? The hope is, future treatments could then target the disease in its earliest stages, before irreversible brain damage or mental decline has occurred. Research on...
Alzheimer's research news / Research
by Alzheimer's Association · Published August 23, 2016 · Last modified August 10, 2016
Growing research evidence suggests that decreased ability to correctly identify odors is a predictor of cognitive decline and an early clinical feature of Alzheimer’s disease. The potential of using smell and eye tests to...